Fresenius SE & Co. KGaA Stock Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 22.96B 24.55B | Sales 2025 * | 24.06B 25.73B | Capitalization | 15.33B 16.39B |
---|---|---|---|---|---|
Net income 2024 * | 1.42B 1.52B | Net income 2025 * | 1.76B 1.88B | EV / Sales 2024 * | 1.29 x |
Net Debt 2024 * | 14.27B 15.26B | Net Debt 2025 * | 13.48B 14.41B | EV / Sales 2025 * | 1.2 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
8.66
x | Employees | - |
Yield 2024 * |
3.43% | Yield 2025 * |
3.89% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 21-04-11 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 18-12-31 |
Michael Moser
CMP | Compliance Officer | - | 23-07-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 15-05-19 |
Director/Board Member | 63 | 16-05-12 | |
Konrad Kölbl
BRD | Director/Board Member | 64 | 07-07-15 |
1st Jan change | Capi. | |
---|---|---|
-14.92% | 84.87B | |
+13.30% | 83.08B | |
+10.92% | 29.4B | |
-12.71% | 16.72B | |
-2.63% | 15.04B | |
-3.97% | 11.88B | |
-1.42% | 11.88B | |
-31.75% | 11.86B | |
+27.44% | 11.64B |